Safety and Efficacy of Dexmedetomidine Addition to Intrathecal Morphine for Postoperative Analgesia in Cancer Patients Undergoing Major Abdominal Surgery

Trial Profile

Safety and Efficacy of Dexmedetomidine Addition to Intrathecal Morphine for Postoperative Analgesia in Cancer Patients Undergoing Major Abdominal Surgery

Completed
Phase of Trial: Phase II/III

Latest Information Update: 09 May 2015

At a glance

  • Drugs Dexmedetomidine (Primary) ; Bupivacaine; Morphine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms ITMandDEX
  • Most Recent Events

    • 09 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top